Role of natriuretic peptides in the assessment of aortic stenosis severity [PDF]
Vojnosanitetski Pregled, 2010 Background/Aim. Symptom onset is a critical point in natural course of aortic stenosis and the most important indication for aortic valve replacement.
Davičević Žaklina +4 more
doaj +1 more source
Journal of the American College of Cardiology, 2007 Natriuretic peptides (NPs) are released from the heart in response to pressure and volume overload. B-type natriuretic peptide (BNP) and N-terminal-proBNP have become important diagnostic tools for assessing patients who present acutely with dyspnea. The NP level reflects a compilation of systolic and diastolic function as well as right ventricular and
Daniels, Lori B., Maisel, Alan S.
openaire +4 more sources
Association of N-terminal pro-brain natriuretic peptide with cognitive function and depression in elderly people with type 2 diabetes [PDF]
, 2012 <p>Background: Type 2 diabetes mellitus is associated with risk of congestive heart failure (CHF), cognitive dysfunction and depression. CHF itself is linked both to poor cognition and depression.
, +7 more
core +6 more sources
Biology, 2022 The field of natriuretic peptides (NPs) as an endocrine hormone has been developing since 1979. There are three peptides in humans: atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP), which bind to the guanylyl cyclase-A (GC-A ...
Tomoko Ichiki +2 more
doaj +1 more source
Natriuretic Peptides and Metabolic Hypertension [PDF]
JACC: Basic to Translational ScienceJens P. Goetze, MD, DMSc +1 more
doaj +2 more sources
Comprehensive exploration of unexplained dyspnoea in subjects with normal ejection fraction and low natriuretic peptides. [PDF]
ESC Heart FailAbstract Background Unexplained exertional dyspnoea without significant elevation of natriuretic peptides is common. One of the causes might be early heart failure with preserved ejection fraction (HFpEF). Aims This study aimed to characterize patients with exertional dyspnoea and normal/near‐to‐normal N‐terminal pro‐brain natriuretic peptide (NT ...
Berthelot E +8 more
europepmc +2 more sources
Natriuretic peptides and cardiovascular damage in the metabolic syndrome. Molecular mechanisms and clinical implications [PDF]
, 2010 Natriuretic peptides are endogenous antagonists of vasoconstrictor and salt- and water-retaining systems in the body's defence against blood pressure elevation and plasma volume expansion, through direct vasodilator, diuretic and natriuretic properties ...
ALONZO, ALESSANDRO +4 more
core +1 more source
Atrial fibrillation impairs the diagnostic performance of cardiac natriuretic peptides in dyspneic patients. results from the BACH Study (Biomarkers in ACute Heart Failure) [PDF]
, 2013 Objectives: The purpose of this study was to assess the impact of atrial fibrillation (AF) on the performance of mid-region amino terminal pro-atrial natriuretic peptide (MR-proANP) in comparison with the B-type peptides (BNP and NT-proBNP) for diagnosis
Anand I +19 more
core +1 more source
Natriuretic peptides appeared after their receptors in vertebrates
BMC Evolutionary Biology, 2019 Background In mammals, the natriuretic system contains three natriuretic peptides, NPPA, NPPB and NPPC, that bind to three transmembrane receptors, NPR1, NPR2 and NPR3. The natriuretic peptides are known only in vertebrates.
Anna Grandchamp +2 more
doaj +1 more source
Modified natriuretic peptides and their potential roles in cancer treatment
Biomedical Journal, 2022 The natriuretic peptide family (NPs) is a group of natural endocrine hormones, containing a 17-amino acid ring structure connected by disulfide bonds of two cysteines.
Mengjiao Xu +9 more
doaj +1 more source